Status:
COMPLETED
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Mclean Hospital
Conditions:
Cocaine-Related Disorders
Heroin Dependence
Eligibility:
MALE
26-41 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
September 1 1989
Trial Type :
INTERVENTIONAL
End Date :
February 1 1996
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000211
Start Date
September 1 1989
End Date
February 1 1996
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States, 2178